SEC 13F Intelligence

Lion Point Capital, LP / MCRB

Lion Point Capital, LP’s Seres Therapeutics Inc Position

Does Lion Point Capital, LP own Seres Therapeutics Inc (MCRB)? Yes — 31.6K shares worth $280,026 (+1.67% of its 13F portfolio) as of Q1 2026.

Position Value
$280,026
Q1 2026
Shares
31.6K
% of Portfolio
+1.67%
Quarters Held
4
currently held

Position History MCRB

Reported value by quarter
Q2 ’25: $189,292Q2 ’25Q3 ’25: $522,135Q3 ’25Q4 ’25: $469,762Q4 ’25Q1 ’26: $280,026Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202631.6K$280,026+1.67%
Q4 202531.6K$469,762+2.43%
Q3 202527.1K$522,135+2.97%
Q2 202517.0K$189,292+1.29%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of MCRB.